MedTrace Logo

Magnesium After Alcohol Withdrawal Treatment

NCT00325299 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 178

Last updated 2006-05-12

No results posted yet for this study

Summary

The primary purpose is to see if magnesium tablet supplementation will decrease elevated GGT enzyme activity in alcoholic patients immediately after they had been treated for alcohol withdrawal. The secondary aims are to find out whether supplementation decreases the activity of ASAT and ALAT enzymes, increases muscle strength, decreases blood pressure and decreases depressive symptoms among these patients.

Conditions

  • Alcohol-Induced Disorders

Interventions

DRUG

Magnesium

Sponsors & Collaborators

  • Finnish Foundation for Alcohol Studies

    lead OTHER

Principal Investigators

  • Kari Poikolainen, Dr Med Sci · Finnish Foundation for Alcohol Studies

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Completion
2005-09-30

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00325299 on ClinicalTrials.gov